Liquid Biopsies for Molecular Biology-Based Radiotherapy

Molecular alterations drive cancer initiation and evolution during development and in response to therapy. Radiotherapy is one of the most commonly employed cancer treatment modalities, but radiobiologic approaches for personalizing therapy based on tumor biology and individual risks remain to be de...

Full description

Bibliographic Details
Main Authors: Erik S. Blomain, Everett J. Moding
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/20/11267
_version_ 1797514327131947008
author Erik S. Blomain
Everett J. Moding
author_facet Erik S. Blomain
Everett J. Moding
author_sort Erik S. Blomain
collection DOAJ
description Molecular alterations drive cancer initiation and evolution during development and in response to therapy. Radiotherapy is one of the most commonly employed cancer treatment modalities, but radiobiologic approaches for personalizing therapy based on tumor biology and individual risks remain to be defined. In recent years, analysis of circulating nucleic acids has emerged as a non-invasive approach to leverage tumor molecular abnormalities as biomarkers of prognosis and treatment response. Here, we evaluate the roles of circulating tumor DNA and related analyses as powerful tools for precision radiotherapy. We highlight emerging work advancing liquid biopsies beyond biomarker studies into translational research investigating tumor clonal evolution and acquired resistance.
first_indexed 2024-03-10T06:29:36Z
format Article
id doaj.art-3029ccb37765426fb4db897c88daab1b
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T06:29:36Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-3029ccb37765426fb4db897c88daab1b2023-11-22T18:36:41ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-10-0122201126710.3390/ijms222011267Liquid Biopsies for Molecular Biology-Based RadiotherapyErik S. Blomain0Everett J. Moding1Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USADepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USAMolecular alterations drive cancer initiation and evolution during development and in response to therapy. Radiotherapy is one of the most commonly employed cancer treatment modalities, but radiobiologic approaches for personalizing therapy based on tumor biology and individual risks remain to be defined. In recent years, analysis of circulating nucleic acids has emerged as a non-invasive approach to leverage tumor molecular abnormalities as biomarkers of prognosis and treatment response. Here, we evaluate the roles of circulating tumor DNA and related analyses as powerful tools for precision radiotherapy. We highlight emerging work advancing liquid biopsies beyond biomarker studies into translational research investigating tumor clonal evolution and acquired resistance.https://www.mdpi.com/1422-0067/22/20/11267circulating tumor DNAliquid biopsiesradiation biologybiomarkersprecision oncologytumor evolution
spellingShingle Erik S. Blomain
Everett J. Moding
Liquid Biopsies for Molecular Biology-Based Radiotherapy
International Journal of Molecular Sciences
circulating tumor DNA
liquid biopsies
radiation biology
biomarkers
precision oncology
tumor evolution
title Liquid Biopsies for Molecular Biology-Based Radiotherapy
title_full Liquid Biopsies for Molecular Biology-Based Radiotherapy
title_fullStr Liquid Biopsies for Molecular Biology-Based Radiotherapy
title_full_unstemmed Liquid Biopsies for Molecular Biology-Based Radiotherapy
title_short Liquid Biopsies for Molecular Biology-Based Radiotherapy
title_sort liquid biopsies for molecular biology based radiotherapy
topic circulating tumor DNA
liquid biopsies
radiation biology
biomarkers
precision oncology
tumor evolution
url https://www.mdpi.com/1422-0067/22/20/11267
work_keys_str_mv AT eriksblomain liquidbiopsiesformolecularbiologybasedradiotherapy
AT everettjmoding liquidbiopsiesformolecularbiologybasedradiotherapy